| 000 | 01798 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250511193608.0 | ||
| 264 | 0 | _c19920626 | |
| 008 | 199206s 0 0 eng d | ||
| 022 | _a0028-4793 | ||
| 024 | 7 |
_a10.1056/NEJM199206253262605 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCurtis, R E | |
| 245 | 0 | 0 |
_aRisk of leukemia after chemotherapy and radiation treatment for breast cancer. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _cJun 1992 |
||
| 300 |
_a1745-51 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlkylating Agents _xadverse effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aCombined Modality Therapy _xadverse effects |
| 650 | 0 | 4 |
_aCyclophosphamide _xadverse effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDose-Response Relationship, Radiation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia _xetiology |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xetiology |
| 650 | 0 | 4 |
_aLeukemia, Radiation-Induced _xetiology |
| 650 | 0 | 4 |
_aMelphalan _xadverse effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyelodysplastic Syndromes _xetiology |
| 650 | 0 | 4 |
_aRadiotherapy _xadverse effects |
| 650 | 0 | 4 | _aRadiotherapy Dosage |
| 650 | 0 | 4 | _aRisk |
| 700 | 1 | _aBoice, J D | |
| 700 | 1 | _aStovall, M | |
| 700 | 1 | _aBernstein, L | |
| 700 | 1 | _aGreenberg, R S | |
| 700 | 1 | _aFlannery, J T | |
| 700 | 1 | _aSchwartz, A G | |
| 700 | 1 | _aWeyer, P | |
| 700 | 1 | _aMoloney, W C | |
| 700 | 1 | _aHoover, R N | |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 326 _gno. 26 _gp. 1745-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJM199206253262605 _zAvailable from publisher's website |
| 999 |
_c1600498 _d1600498 |
||